TGM2 and cystic fibrosis: Intraperitoneal administration of NAC has been shown to decrease TGM2 SUMOylation, and restore normal levels of autophagy in 2 CF mouse models, supporting the therapeutic potential of antioxidant therapy in the treatment of CF-associated infections.3